Watch Demo

Regulatory Affairs Market Research Report by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

Regulatory Affairs Market Research Report by Services, Indication, Stage, Category, Service Provider, Company Size, End-Use, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:157

  • Report ID:6406001

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Regulatory Affairs Market Research Report by Services (Legal Representation, Product Registration & Clinical Trial Applications, and Regulatory Consulting), Indication, Stage, Category, Service Provider, Company Size, End-Use, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

The North America Regulatory Affairs Market size was estimated at USD 2,963.57 million in 2022 and expected to reach USD 3,222.97 million in 2023, projecting growth at a CAGR of 10.22% to reach USD 6,459.24 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the North America Regulatory Affairs Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the North America Regulatory Affairs Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The North America Regulatory Affairs Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the North America Regulatory Affairs Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the North America Regulatory Affairs Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Services, the market is studied across Legal Representation, Product Registration & Clinical Trial Applications, Regulatory Consulting, and Regulatory Writing & Publishing.

Based on Indication, the market is studied across Cardiology, Immunology, Neurology, and Oncology.

Based on Stage, the market is studied across Clinical Studies and Preclinical.

Based on Category, the market is studied across Biologics, Drugs, and Medical Devices. The Biologics is further studied across Biosimilars and Biotech. The Drugs is further studied across Generics and Innovator. The Medical Devices is further studied across Diagnostics and Therapeutics.

Based on Service Provider, the market is studied across In-House and Outsourced.

Based on Company Size, the market is studied across Large, Medium, and Small.

Based on End-Use, the market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.

Based on Country, the market is studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the North America Regulatory Affairs Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The North America Regulatory Affairs Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The North America Regulatory Affairs Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The North America Regulatory Affairs Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Regulatory Affairs Market, including Asphalion, S.L., Cambridge Regulatory Services, Charles River Laboratories, Inc., Clinilabs Inc., Educo Life Sciences Ltd, Exalon GmbH, Genpact Ltd., ICON PLC, IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Medpace Inc., NDA Group AB, Pharmalex GMBH, Qvigilance, and WuXi AppTec Co. Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the North America Regulatory Affairs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Regulatory Affairs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Regulatory Affairs Market?
4. What is the competitive strategic window for opportunities in the North America Regulatory Affairs Market?
5. What are the technology trends and regulatory frameworks in the North America Regulatory Affairs Market?
6. What is the market share of the leading vendors in the North America Regulatory Affairs Market?
7. What modes and strategic moves are considered suitable for entering the North America Regulatory Affairs Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Regulatory Affairs Market, by Services
6.1. Introduction
6.2. Legal Representation
6.3. Product Registration & Clinical Trial Applications
6.4. Regulatory Consulting
6.5. Regulatory Writing & Publishing

7. Regulatory Affairs Market, by Indication
7.1. Introduction
7.2. Cardiology
7.3. Immunology
7.4. Neurology
7.5. Oncology

8. Regulatory Affairs Market, by Stage
8.1. Introduction
8.2. Clinical Studies
8.3. Preclinical

9. Regulatory Affairs Market, by Category
9.1. Introduction
9.2. Biologics
9.3.1. Biosimilars
9.3.2. Biotech
9.3. Drugs
9.4.1. Generics
9.4.2. Innovator
9.4. Medical Devices
9.5.1. Diagnostics
9.5.2. Therapeutics

10. Regulatory Affairs Market, by Service Provider
10.1. Introduction
10.2. In-House
10.3. Outsourced

11. Regulatory Affairs Market, by Company Size
11.1. Introduction
11.2. Large
11.3. Medium
11.4. Small

12. Regulatory Affairs Market, by End-Use
12.1. Introduction
12.2. Biotechnology Companies
12.3. Medical Device Companies
12.4. Pharmaceutical Companies

13. Canada Regulatory Affairs Market
13.1. Introduction

14. Mexico Regulatory Affairs Market
14.1. Introduction

15. United States Regulatory Affairs Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Asphalion, S.L.
17.2. Cambridge Regulatory Services
17.3. Charles River Laboratories, Inc.
17.4. Clinilabs Inc.
17.5. Educo Life Sciences Ltd
17.6. Exalon GmbH
17.7. Genpact Ltd.
17.8. ICON PLC
17.9. IQVIA Holdings Inc.
17.10. Laboratory Corporation of America Holdings
17.11. Medpace Inc.
17.12. NDA Group AB
17.13. Pharmalex GMBH
17.14. Qvigilance
17.15. WuXi AppTec Co. Ltd.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. NORTH AMERICA REGULATORY AFFAIRS MARKET: RESEARCH PROCESS
FIGURE 2. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, 2022 VS 2030
FIGURE 3. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 5. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 7. NORTH AMERICA REGULATORY AFFAIRS MARKET DYNAMICS
FIGURE 8. NORTH AMERICA REGULATORY AFFAIRS MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
FIGURE 10. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICES, 2030
FIGURE 12. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, 2018-2030 (USD MILLION)
FIGURE 13. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, 2018-2030 (USD MILLION)
FIGURE 14. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, 2018-2030 (USD MILLION)
FIGURE 15. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, 2018-2030 (USD MILLION)
FIGURE 16. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 17. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 19. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
FIGURE 20. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
FIGURE 21. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
FIGURE 22. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
FIGURE 23. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2030 (%)
FIGURE 24. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY STAGE, 2030
FIGURE 26. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, 2018-2030 (USD MILLION)
FIGURE 27. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
FIGURE 28. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2030 (%)
FIGURE 29. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY CATEGORY, 2030
FIGURE 31. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
FIGURE 32. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, 2018-2030 (USD MILLION)
FIGURE 33. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, 2018-2030 (USD MILLION)
FIGURE 34. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
FIGURE 35. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, 2018-2030 (USD MILLION)
FIGURE 36. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, 2018-2030 (USD MILLION)
FIGURE 37. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
FIGURE 38. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
FIGURE 39. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
FIGURE 40. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2030 (%)
FIGURE 41. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 42. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE PROVIDER, 2030
FIGURE 43. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
FIGURE 44. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
FIGURE 45. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2030 (%)
FIGURE 46. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 47. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY COMPANY SIZE, 2030
FIGURE 48. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LARGE, 2018-2030 (USD MILLION)
FIGURE 49. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, 2018-2030 (USD MILLION)
FIGURE 50. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SMALL, 2018-2030 (USD MILLION)
FIGURE 51. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 52. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 53. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 54. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
FIGURE 55. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
FIGURE 56. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 57. CANADA REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. MEXICO REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 61. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 62. UNITED STATES REGULATORY AFFAIRS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 63. NORTH AMERICA REGULATORY AFFAIRS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 64. NORTH AMERICA REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 65. NORTH AMERICA REGULATORY AFFAIRS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. NORTH AMERICA REGULATORY AFFAIRS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 5. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 6. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, 2018-2030 (USD MILLION)
TABLE 7. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LEGAL REPRESENTATION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 9. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRODUCT REGISTRATION & CLINICAL TRIAL APPLICATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 10. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, 2018-2030 (USD MILLION)
TABLE 11. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY CONSULTING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 12. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, 2018-2030 (USD MILLION)
TABLE 13. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 16. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 20. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 22. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 24. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, 2018-2030 (USD MILLION)
TABLE 25. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CLINICAL STUDIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, 2018-2030 (USD MILLION)
TABLE 27. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 29. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 30. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, 2018-2030 (USD MILLION)
TABLE 32. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, 2018-2030 (USD MILLION)
TABLE 34. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, 2018-2030 (USD MILLION)
TABLE 38. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, 2018-2030 (USD MILLION)
TABLE 40. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY INNOVATOR, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 42. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 44. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 46. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 48. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, 2018-2030 (USD MILLION)
TABLE 49. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, 2018-2030 (USD MILLION)
TABLE 51. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY OUTSOURCED, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 53. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LARGE, 2018-2030 (USD MILLION)
TABLE 54. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY LARGE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, 2018-2030 (USD MILLION)
TABLE 56. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SMALL, 2018-2030 (USD MILLION)
TABLE 58. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY SMALL, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 61. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, 2018-2030 (USD MILLION)
TABLE 63. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 65. NORTH AMERICA REGULATORY AFFAIRS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. CANADA REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 70. CANADA REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 71. CANADA REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 72. CANADA REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 73. CANADA REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY STAGE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY SERVICE PROVIDER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY COMPANY SIZE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES REGULATORY AFFAIRS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. NORTH AMERICA REGULATORY AFFAIRS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 92. NORTH AMERICA REGULATORY AFFAIRS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 93. NORTH AMERICA REGULATORY AFFAIRS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 94. NORTH AMERICA REGULATORY AFFAIRS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 95. NORTH AMERICA REGULATORY AFFAIRS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 96. NORTH AMERICA REGULATORY AFFAIRS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 97. NORTH AMERICA REGULATORY AFFAIRS MARKET MERGER & ACQUISITION
TABLE 98. NORTH AMERICA REGULATORY AFFAIRS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 99. NORTH AMERICA REGULATORY AFFAIRS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 100. NORTH AMERICA REGULATORY AFFAIRS MARKET INVESTMENT & FUNDING
TABLE 101. NORTH AMERICA REGULATORY AFFAIRS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 102. NORTH AMERICA REGULATORY AFFAIRS MARKET: LICENSE & PRICING

Companies Mentioned

Asphalion, S.L.
Cambridge Regulatory Services
Charles River Laboratories, Inc.
Clinilabs Inc.
Educo Life Sciences Ltd
Exalon GmbH
Genpact Ltd.
ICON PLC
IQVIA Holdings Inc.
Laboratory Corporation of America Holdings
Medpace Inc.
NDA Group AB
Pharmalex GMBH
Qvigilance
WuXi AppTec Co. Ltd.

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.